• Susan Monarez selected as new CDC nominee after David Weldon's withdrawal.
  • Monarez brings AI and health tech expertise from her ARPA-H and acting CDC roles.
  • Nomination marks first CDC director requiring Senate confirmation under new law.

A New Direction for CDC Leadership

President Trump has chosen Susan Monarez as his nominee to lead the Centers for Disease Control and Prevention, according to sources familiar with the decision. The move comes just weeks after the withdrawal of previous nominee David Weldon, whose vaccine skepticism drew opposition from Republican senators.

Monarez, who has served as acting CDC director since January, brings substantial health technology credentials to the role. Her background includes serving as Deputy Director of ARPA-H, the advanced health research agency created during the Biden administration. "She understands how to leverage emerging technologies in public health," said one administration official who requested anonymity.

Confirmation Challenges Ahead

The nomination arrives at a pivotal moment for the agency, which faces both ongoing pandemic recovery efforts and potential legislative reforms. A Republican working group is currently examining possible changes to the CDC's structure and mandate. Monarez would be the first CDC director subject to Senate confirmation under legislation passed in 2022.

Two other health nominees - Dr. Marty Makary for FDA commissioner and Dr. Jay Bhattacharya for NIH director - appear to have smoother paths to confirmation, according to congressional sources. The White House declined to comment on the timing of formal nomination paperwork.

Technical Expertise Meets Political Reality

Monarez's selection suggests an emphasis on technological modernization at the embattled agency. Her work at ARPA-H focused on artificial intelligence applications in healthcare, a growing priority across federal health agencies. However, some public health advocates have quietly questioned whether her research background provides sufficient preparation for the CDC's operational challenges.

The Senate HELP Committee is expected to schedule confirmation hearings within the next month, though the timeline remains fluid. A committee spokesperson said they had not yet received official notification of the nomination as of Thursday afternoon.